Cite
HARVARD Citation
van den Elzen, F. et al. (2021). OS05.7.A Absence of severe hematological toxicity during first line treatment predicts low chance on severe toxicity during second line alkylating chemotherapy in glioblastoma. Neuro-oncology. p. ii8. [Online].